Market Leaders - Desmoid Tumors Industry

Desmoid tumor are connective tissue growths that aren’t malignant. These tumors usually develop in the arms, legs and belly. It is also referred to as aggressive fibromatosis. Some desmoid tumor grow at a slow place and hence do not need to be treated right away, while others have a rapid rate of growth and are treated with surgery, chemotherapy, radiation, therapy, or other medications.

As of 2022 the Global Desmoid Tumors Market is estimated to be valued at US$ 2,494. 1 Million and is expected to exhibit a CAGR of 7.3% during the years (2022-2030).

1) Novartis AG

Novartis AG is a Swiss pharmaceutical corporation founded in March 1996 by Johann Rudolf The headquarters are located in Basel Switzerland, Cambridge, The United States of America and Massachusetts. It is one of the largest Pharma based company incorporated. The drugs manufactured are sold worldwide.

In June, 2022 Novartis completed the acquisition of Kedalion Therapeutics and its AcuStream technology.

2) Hikma Pharmaceuticals

Hikma Pharmaceuticals Plc. Is a multinational pharmaceutical company that was the first Arab company to export pharmaceutical products in the U.S. The Company was founded in the year 1978 by Samih Darwazah. The Headquarters are located in London, England, UK. Products manufactured include Amoclan, Prograf, and Suprax.

In January 2023, The Company launched Naloxone Hydrochloride Injection, in prefilled syringe form, which is used for the emergency treatment of opioid overdose.

3) Abbott Laboratories

Abbott Laboratories is a medical device and health care company based in America. It was founded in the year 1888 by Wallace Calvin Abbott. The headquarters are located in Abbott Park, Illinois, U.S. The company sells medical devices, branded generic medicines and nutritional products. Abbott’s products include MitraClip, FreeStyle Libre, Pedialyte, and Ensure.

In January 2022, the company introduced Lingo, which is a line of consumer bio wearable sensors known to collect a range of biological reading to optimize exercise and nutrition regimens.

4) Bayer AG

Bayer AG is a pharmaceutical and biotechnology company situated in Germany. It is one of the largest pharma company in the world. The headquarters are located in Leverkusen, North Rhine- Westphalia, Germany. The company was founded in the year 1863 by Friedrich Bayer. Bayer AG’s first ever manufactured product was acetylsalicylic acid.

Since then it has manufactured many more products like heroin, phenobarbital, polyurethanes, however stopped producing them. The area of business is mainly healthcare products for consumers, agricultural chemicals.

5) Apotex Inc

Apotex Inc. is a pharmaceutical corporation based in Canada. Apotex is the largest producer of generic drugs in Canada. The company manufactures and sells generic medications for diseases like cancer, diabetes, high cholesterol and blood pressure. The company was founded in the year 1974 and the headquarters are located in Toronto, Ontario, Canada. The company was founded by Barry Sherman.

In July, 2022 Apotex Inc. announced the launch of APO-Apixaban tablets. Canada’s first generic alternative to Eliquis. 

6) Endo International Plc.

Endo International Plc. Is a domiciled generics and speciality branded pharmaceutical company. The company was founded in the year 1997 and the headquarters are located in Dublin, Ireland. Malvern, Pennsylvania, United States. The company was founded by Carol Ammon.

7) Amneal Pharmaceuticals

Amneal Pharmaceuticals is a publicly traded generics and speciality pharmaceutical company that focuses on a wide range of therapeutics areas that include solid oral dosage products and alternative dosage form products. The company was founded in the year 2002 and the headquarters are located Bridgewater, New Jersey. The company was founded by Chirag Patel, Chintu Patel.

In April, 2021 Amneal Corporation completed the acquisition of Kashiv Speciality Pharmaceuticals, for the development of complex generics.

More Insights:

Circulating Cell free tumor DNA

Compounding Chemotherapy Industry